OSBPL1A
Basic information
Region (hg38): 18:24162045-24397880
Previous symbols: [ "OSBPL1B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OSBPL1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 41 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 41 | 0 | 0 |
Variants in OSBPL1A
This is a list of pathogenic ClinVar variants found in the OSBPL1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-24163268-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
18-24165104-C-T | not specified | Uncertain significance (Jun 23, 2023) | ||
18-24165105-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
18-24166614-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
18-24167349-G-A | not specified | Uncertain significance (Aug 11, 2021) | ||
18-24167427-A-T | not specified | Uncertain significance (Apr 19, 2024) | ||
18-24170376-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
18-24170380-C-T | not specified | Uncertain significance (Jun 27, 2022) | ||
18-24170404-T-C | not specified | Uncertain significance (Nov 30, 2022) | ||
18-24170442-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
18-24171461-C-T | not specified | Uncertain significance (May 13, 2024) | ||
18-24172478-T-C | not specified | Uncertain significance (Jun 12, 2023) | ||
18-24178102-G-C | not specified | Uncertain significance (Jun 23, 2023) | ||
18-24178193-T-C | not specified | Uncertain significance (Mar 16, 2022) | ||
18-24179742-C-G | not specified | Uncertain significance (Aug 15, 2023) | ||
18-24179835-A-G | not specified | Uncertain significance (Aug 22, 2023) | ||
18-24181167-G-C | not specified | Uncertain significance (Mar 01, 2023) | ||
18-24181183-T-C | not specified | Uncertain significance (Apr 17, 2023) | ||
18-24225187-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
18-24239249-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
18-24280946-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
18-24303651-C-A | not specified | Uncertain significance (Feb 26, 2024) | ||
18-24303655-C-G | not specified | Uncertain significance (Dec 22, 2023) | ||
18-24303675-T-C | not specified | Uncertain significance (Nov 13, 2023) | ||
18-24312006-G-C | not specified | Uncertain significance (Mar 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OSBPL1A | protein_coding | protein_coding | ENST00000319481 | 27 | 235837 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.58e-7 | 1.00 | 125076 | 1 | 671 | 125748 | 0.00268 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.56 | 405 | 503 | 0.805 | 0.0000256 | 6304 |
Missense in Polyphen | 109 | 177.33 | 0.61467 | 2141 | ||
Synonymous | 0.00543 | 182 | 182 | 0.999 | 0.00000988 | 1685 |
Loss of Function | 4.62 | 23 | 62.4 | 0.369 | 0.00000326 | 731 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00607 | 0.00606 |
Ashkenazi Jewish | 0.000202 | 0.000198 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000279 | 0.000277 |
European (Non-Finnish) | 0.00372 | 0.00365 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.00185 | 0.00180 |
Other | 0.00418 | 0.00392 |
dbNSFP
Source:
- Function
- FUNCTION: Binds phospholipids; exhibits strong binding to phosphatidic acid and weak binding to phosphatidylinositol 3- phosphate (By similarity). Stabilizes GTP-bound RAB7A on late endosomes/lysosomes and alters functional properties of late endocytic compartments via its interaction with RAB7A (PubMed:16176980). Binds 25-hydroxycholesterol and cholesterol (PubMed:17428193). {ECO:0000250, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:17428193}.;
- Pathway
- Metabolism of lipids;Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of steroids
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.877
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.83
Haploinsufficiency Scores
- pHI
- 0.224
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.638
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Osbpl1a
- Phenotype
Gene ontology
- Biological process
- bile acid biosynthetic process;cholesterol metabolic process;sterol transport;vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II
- Cellular component
- late endosome;cytosol;membrane;intracellular membrane-bounded organelle;extracellular exosome
- Molecular function
- protein binding;phospholipid binding;lipid binding;sterol transporter activity;cholesterol binding;sterol binding